You have 9 free searches left this month | for more free features.

LAG525

Showing 1 - 20 of 20

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Triple-negative Breast Cancer Trial in Worldwide (LAG525, Spartalizumab, Carboplatin)

Completed
  • Triple-negative Breast Cancer
  • LAG525
  • +2 more
  • Chandler, Arizona
  • +32 more
Jan 27, 2023

Advanced Solid Tumors Trial in Worldwide (LAG525, PDR001)

Completed
  • Advanced Solid Tumors
  • New York, New York
  • +23 more
Jan 17, 2022

Small Cell Lung Cancer, Gastric Adenocarcinoma, Esophageal Adenocarcinoma Trial in United States (PDR001, LAG525)

Completed
  • Small Cell Lung Cancer
  • +7 more
  • PDR001
  • LAG525
  • San Francisco, California
  • +19 more
May 4, 2022

Migraine, Sleep Disturbance Trial (Feel Bright Light)

Not yet recruiting
  • Migraine
  • Sleep Disturbance
  • Feel Bright Light
  • (no location specified)
May 13, 2021

ConforMIS iTotalĀ® (PS) Knee Replacement System

Recruiting
  • Osteoarthritis, Knee
  • iTotal PS KRS
  • Chapel Hill, North Carolina
  • +3 more
Nov 17, 2020

Alcohol Use Disorder Trial in Arnhem (Alcohol Avoidance Training)

Recruiting
  • Alcohol Use Disorder
  • Alcohol Avoidance Training
  • Arnhem, Gelderland, Netherlands
    IrisZorg
Nov 21, 2022

NSCLC Trial in Canada, United States (Nivolumab, Carboplatin, Paclitaxel)

Recruiting
  • Non-Small Cell Lung Cancer
  • Baltimore, Maryland
  • +4 more
Jul 26, 2022

Chronic Illness Trial in Leuven (Mindfulness-Based Intervention)

Unknown status
  • Chronic Illness
  • Mindfulness-Based Intervention
  • Leuven, Vlaams-Brabant, Belgium
    KU Leuven
Aug 17, 2020

HIV Trial in Worldwide (GSK3640254, Placebo matching GSK3640254 Mesylate salt)

Completed
  • HIV Infections
  • Bakersfield, California
  • +22 more
Jan 27, 2021

Infection, Human Immunodeficiency Virus, HIV Trial in Cambridge (GSK3640254, Placebo)

Completed
  • Infection, Human Immunodeficiency Virus
  • HIV Infections
  • Cambridge, United Kingdom
    GSK Investigational Site
May 28, 2021

Hemophilia A or B Trial in Worldwide (PF-06741086)

Completed
  • Hemophilia A or B
  • PF-06741086
  • Aurora, Colorado
  • +9 more
Nov 15, 2019

Toothache Trial in Italy, Korea, Republic of, United Kingdom (SB705498 400 mg, SB705498 1000 mg, Placebo)

Completed
  • Toothache
  • SB705498 400 mg
  • +3 more
  • Verona, Veneto, Italy
  • +4 more
Aug 10, 2018

HIV Trial in Austin (Treatment A, Treatment B, Treatment C)

Completed
  • HIV Infections
  • Treatment A
  • +5 more
  • Austin, Texas
    GSK Investigational Site
Nov 20, 2019

Dyslipidaemias, Dyslipidemias Trial in United States (10mg atorvastatin, 80mg atorvastatin, GSK1292263 Placebo)

Completed
  • Dyslipidaemias
  • Dyslipidemias
  • 10mg atorvastatin
  • +7 more
  • Anniston, Alabama
  • +20 more
Jul 5, 2019

Infection, Human Immunodeficiency Virus Trial in United States (GSK1265744 30mg, Placebo, GSK1265744 5mg)

Completed
  • Infection, Human Immunodeficiency Virus
  • GSK1265744 30mg
  • +2 more
  • Fort Lauderdale, Florida
  • +3 more
Nov 2, 2017

Sleep, Alertness, Fatigue Trial in Moscow (Bright Light Box)

Completed
  • Sleep
  • +2 more
  • Bright Light Box
  • Moscow, Russian Federation
    Institute of Biomedical Problems in Moscow
Apr 28, 2015

Low Bone Mass, Low Bone Mineral Density, Osteoporosis Trial (Previous denosumab)

Completed
  • Low Bone Mass
  • +3 more
  • Previous denosumab
  • (no location specified)
Oct 23, 2013

Osteoporosis Trial in Worldwide (Bazedoxifene Acetate, Placebo)

Completed
  • Osteoporosis
  • Bazedoxifene Acetate
  • Placebo
  • Birmingham, Alabama
  • +375 more
Feb 28, 2013

Circadian Dysregulation Trial in United States (Ramelteon, Placebo)

Completed
  • Circadian Dysregulation
  • Miami, Florida
  • +3 more
Feb 27, 2012

Mental Retardation, Developmental Delay Disorder Trial in Lawrence (risperidone, clozapine, olanzapine)

Completed
  • Mental Retardation
  • Developmental Delay Disorder
  • Lawrence, Kansas
    University of Kansas
Jun 23, 2005